International Clinical Trial: Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07823595) titled 'Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age' on Sept. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Pfizer

Condition: Atopic Dermatitis

Intervention: Drug: Abrocitinib

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: May 1, 2027

Target Sample Size: 90

To know more, visit https://clinicaltrials.gov/study/NCT07823595

Disclaimer: Curated by HT Syndi...